06 March 2017 – PLC is proud to announce Izun Pharmaceuticals has received FDA approval of their 510(k) application for Curastie™ Hydrogel Wound Care. PLC directed the preparation and filing of the 510(k) application on Izun’s behalf.
Izun Pharmaceuticals Announces Approval of Curasite™ Hydrogel Wound Care Product by FDA
- Product approved for prescription and over the counter indications
